The Long Beach, Calif.-based insurer said it welcomes proposals that seek to recalibrate the agency’s risk adjustment program. The permanent program was intended to shift funds from insurers with low-cost enrollees to plans with high-cost enrollees.
“We welcome the opportunity to work closely with HHS to ensure the risk adjustment program is as accurate and equitable as possible,” said J. Mario Molina, MD, president and CEO of Molina. “We encourage HHS to make these and other improvements sooner rather than later to ensure a viable marketplace for the future, and we look forward to seeing the positive outcomes that will result from these actions.”
In its statement, Molina highlighted HHS’ proposal to incorporate prescription drug data into risk adjustment models and proposals to better predict the risk of low-cost enrollees, which the insurer said are under-accounted for in the current model.
This article was updated at 2:01 p.m. CST to reflect an accurate definition of the risk adjustment program. The previous article defined the risk corridor program. We regret this error.
More articles about payer issues:
Federal estimate of uninsured falls to record low: 7 statistics
States opposed to ACA seeing more exchange struggles
US probe still preventing Cigna from enrolling new Medicare members
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
